Table of Content - Eylea Market

The Global Eylea Market is estimated to be valued at USD 838.6 Mn in 2025 and is expected to reach USD 673.7 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of -3.1% from 2025 to 2032.

The global Eylea market, while a prominent player in the ophthalmology sector, is currently facing a period of decline. Despite its earlier success in revolutionizing the treatment of retinal vascular diseases like neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME), the market is now experiencing a negative growth trend. This decline is primarily attributed to the emergence of alternative therapies, the high cost of Eylea, and the increasing competition from other anti-VEGF agents.

Market Dynamics

Several factors are contributing to the market’s downward trajectory. Although the prevalence of eye disorders and the growing geriatric population remain significant drivers of demand, the high price point of Eylea limits its accessibility, particularly in developing regions where alternative, more affordable options are becoming available. Furthermore, newer treatments are providing comparable efficacy, leading to increased market fragmentation.

Despite these challenges, there are still opportunities within the market. Ongoing research and development aimed at improving Eylea’s efficacy and exploring new drug delivery systems, such as sustained-release formulations, may mitigate some of the market's negative growth. Additionally, the expanding indications for Eylea, such as for retinal vein occlusion and choroidal neovascularization, offer some potential for market recovery.

Key Features of the Study

This report provides an in-depth analysis of the global Eylea market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key player
It profiles key players in the global Eylea market based on the following parameters: company highlights, product portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Regeneron Pharmaceuticals, Inc. and Bayer AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Eylea market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Eylea market

Market Segmentation

Indication Insights (Revenue, USD Mn, 2020 - 2032)
- Neovascular (Wet) Age-Related Macular Degeneration (AMD)
- Macular Edema Following Retinal Vein Occlusion (RVO)
- Diabetic Macular Edema (DME)
- Diabetic Retinopathy (DR)
- Retinopathy of Prematurity (ROP)
Dosage Strength Insights (Revenue, USD Mn, 2020 - 2032)
- 2 mg
- 4 mg
- 8 Mg
Packaging Insights (Revenue, USD Mn, 2020 - 2032)
- Pre-filled Syringe
- Vial
Patient Age Group Insights (Revenue, USD Mn, 2020 - 2032)
- Pediatric
- Adult
- Geriatric
Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - North Africa
  - Central Africa
Key Players Insights
- Regeneron Pharmaceuticals
- Bayer AG

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global Eylea Market, By Indication
  - Global Eylea Market, By Dosage Strength
  - Global Eylea Market, By Packaging
  - Global Eylea Market, By Patient Age Group
  - Global Eylea Market, By Distribution Channel
  - Global Eylea Market, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- Merger and Acquisition Scenario
- Industry Trends
Global Eylea Market, By Indication, 2020-2032, (USD Mn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- Neovascular (Wet) Age-Related Macular Degeneration (AMD)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Macular Edema Following Retinal Vein Occlusion (RVO)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Diabetic Macular Edema (DME)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Diabetic Retinopathy (DR)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Retinopathy of Prematurity (ROP)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Global Eylea Market, By Dosage Strength, 2020-2032, (USD Mn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- 2 mg
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- 4 mg
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- 8 Mg
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Global Eylea Market, By Packaging, 2020-2032, (USD Mn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- Pre-filled Syringe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Vial
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Global Eylea Market, By Patient Age Group, 2020-2032, (USD Mn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- Pediatric
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Adult
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Geriatric
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Global Eylea Market, By Distribution Channel, 2020-2032, (USD Mn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Global Eylea Market, By Region, 2020 - 2032, Value (USD Mn)
- Introduction
  - Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
  - Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Dosage Strength, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Packaging, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Dosage Strength, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Packaging, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Dosage Strength, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Packaging, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Dosage Strength, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Packaging, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Dosage Strength, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Packaging, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Dosage Strength, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Packaging, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Regeneron Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

*Browse 32 market data tables and 28 figures on ‘Eylea Market' - Global forecast to 2032

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

EYLEA MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)

Need a Custom Report?

EXISTING CLIENTELE